Eric Crombez Ultragenyx Pharmaceutical Inc. (RARE) insider trading activity

RARE Quotes by TradingView

Eric Crombez is EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc.. Currently has a direct ownership of 48,431 shares of RARE, which is worth approximately $2.29 Million. The most recent transaction as insider was on May 02, 2024, when has been sold 354 shares (Common Stock) at a price of $43.66 per share, resulting in proceeds of $15,455. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.4K
0% 3M change
58.73% 12M change
Total Value Held $2.29 Million

Eric Crombez Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 02 2024
SELL
Open market or private sale
$15,455 $43.66 p/Share
354 Reduced 0.73%
48,431 Common Stock
Apr 18 2024
SELL
Open market or private sale
$6,262 $44.1 p/Share
142 Reduced 0.29%
48,785 Common Stock
Mar 01 2024
SELL
Open market or private sale
$66,554 $53.76 p/Share
1,238 Reduced 2.47%
48,927 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
19,400 Added 27.99%
49,912 Common Stock
May 01 2023
BUY
Grant, award, or other acquisition
-
4,658 Added 13.24%
30,512 Common Stock

Also insider at

ABEO
ABEONA THERAPEUTICS INC. Healthcare
Director
EC

Eric Crombez

EVP and Chief Medical Officer
Novato, CA

Track Institutional and Insider Activities on RARE

Follow Ultragenyx Pharmaceutical Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RARE shares.

Notify only if

Insider Trading

Get notified when an Ultragenyx Pharmaceutical Inc. insider buys or sells RARE shares.

Notify only if

News

Receive news related to Ultragenyx Pharmaceutical Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RARE